Literature DB >> 2227804

Chronic ethanol administration impairs receptor-mediated endocytosis of epidermal growth factor by rat hepatocytes.

D D Dalke1, M F Sorrell, C A Casey, D J Tuma.   

Abstract

The effects of chronic ethanol administration on the receptor-mediated endocytosis of epidermal growth factor were studied in isolated rat hepatocytes. In initial experiments, it was demonstrated that significantly less ligand was bound by hepatocytes isolated from rats fed an ethanol liquid diet for 5 to 7 wk than by cells isolated from chow-fed or pair-fed controls. Reduced binding was shown to be primarily caused by a decreased number of surface receptors rather than by changes in receptor affinity. When hepatocytes were incubated at 37 degrees C in the presence of a large saturating concentration of epidermal growth factor (80 nmol/L), intracellular levels of the ligand were significantly lower in cells from the ethanol-fed animals. However, no effect on degradation of the ligand was observed under those conditions. A defect in the initial stages of receptor-ligand internalization was also indicated because less surface-bound ligand was internalized and subsequently degraded in cells from the ethanol-treated rats. When the endocytosis of a lower, more physiological concentration of the growth factor (0.5 nmol/L) was studied, both the uptake of ligand and its degradation were markedly impaired in hepatocytes from the ethanol-fed animals. These results indicate that chronic ethanol administration impairs the receptor-mediated endocytosis of epidermal growth factor by the liver. The major impairment appears to be a reduction of cell surface receptors; however, other steps of the endocytotic pathway also appear to be affected. These altered steps include defective receptor-ligand internalization and changes in intracellular processing of the ligand leading to decreased degradation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2227804     DOI: 10.1002/hep.1840120502

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

1.  Ethanol increases receptor-dependent cyclic AMP production in cultured hepatocytes by decreasing G(i)-mediated inhibition.

Authors:  L E Nagy; S E DeSilva
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

Review 2.  Pathogenesis of alcoholic liver disease: interactions between parenchymal and non-parenchymal cells.

Authors:  Jessica I Cohen; Laura E Nagy
Journal:  J Dig Dis       Date:  2011-02       Impact factor: 2.325

Review 3.  Alcohol-induced protein hyperacetylation: mechanisms and consequences.

Authors:  Blythe D Shepard; Pamela L Tuma
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

4.  Microtubule acetylation and stability may explain alcohol-induced alterations in hepatic protein trafficking.

Authors:  Rohan A Joseph; Blythe D Shepard; George T Kannarkat; Tara M Rutledge; Dean J Tuma; Pamela L Tuma
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

Review 5.  A Mechanistic Review of Cell Death in Alcohol-Induced Liver Injury.

Authors:  Shaogui Wang; Pal Pacher; Robert C De Lisle; Heqing Huang; Wen-Xing Ding
Journal:  Alcohol Clin Exp Res       Date:  2016-04-30       Impact factor: 3.455

6.  Alcohol consumption impairs hepatic protein trafficking: mechanisms and consequences.

Authors:  Blythe D Shepard; David J Fernandez; Pamela L Tuma
Journal:  Genes Nutr       Date:  2009-11-05       Impact factor: 5.523

7.  Ethanol selectively impairs clathrin-mediated internalization in polarized hepatic cells.

Authors:  David J Fernandez; Benita L McVicker; Dean J Tuma; Pamela L Tuma
Journal:  Biochem Pharmacol       Date:  2009-05-20       Impact factor: 5.858

8.  Cyanamide potentiates the ethanol-induced impairment of receptor-mediated endocytosis in a recombinant hepatic cell line expressing alcohol dehydrogenase activity.

Authors:  Dahn L Clemens; Dean J Tuma; Carol A Casey
Journal:  Int J Hepatol       Date:  2012-02-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.